Trends in lipid-modifying agent use in 83 countries

Lipid-modifying therapy in the elderly

Cardiovascular disease (CVD) mortality and morbidity increases with increasing age, largely as a result of increased lifetime exposure as well as increased prevalence of CVD risk factors. Hospitalization for CVD increases by a factor of over 18× for those aged 85+ years versus those aged <30 years. In spite of this, life expectancy continues to increase, and in Australia for people reaching the...

Trends in hospital utilization, 1982-83 to 1992-93.

Frequency and trends of disease‐modifying antirheumatic drug (DMARD) use in Germany

The aim of this study was to analyze the population-based frequency of classic (c-) and biologic (b-) disease-modifying antirheumatic drug (DMARD) use over time, selected underlying indications and the specialty of the prescribing physicians in Germany. Based on the claims data of the German Pharmacoepidemiological Research Database (GePaRD), yearly cross-sectional studies were conducted from 2...

Trends in nuclear medicine in developing countries.

This article describes trends in nuclear medicine in the developing world as noted by nuclear medicine professionals at the International Atomic Energy Agency (IAEA). The trends identified are based on data gathered from several sources, including information gathered through a database maintained by the IAEA; evaluation of country program frameworks of various IAEA Member States; personal inte...

Trends in Agent Communication Language

Agent technology is an exciting and important new way to create complex software systems. Agents blend many of the traditional properties of AI programs knowledge-level reasoning, flexibility, pro-activeness, goal-directedness, and so forth with insights gained from distributed software engineering, machine learning, negotiation and teamwork theory, and the social sciences. An important part of...